Cartesian Therapeutics (STU:1S70) Accumulated Depreciation : €-5.36 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cartesian Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cartesian Therapeutics's quarterly accumulated depreciation declined from Sep. 2023 (€-5.38 Mil) to Dec. 2023 (€-5.25 Mil) but then increased from Dec. 2023 (€-5.25 Mil) to Mar. 2024 (€-5.36 Mil).

Cartesian Therapeutics's annual accumulated depreciation increased from Dec. 2021 (€-4.25 Mil) to Dec. 2022 (€-4.91 Mil) and increased from Dec. 2022 (€-4.91 Mil) to Dec. 2023 (€-5.25 Mil).

Cartesian Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Cartesian Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartesian Therapeutics Accumulated Depreciation Chart

Cartesian Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-4.30

-3.50

-4.25

-4.91

-5.25

Cartesian Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-5.04	-5.15	-5.38	-5.25	-5.36

Cartesian Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cartesian Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cartesian Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cartesian Therapeutics (STU:1S70) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (STU:1S70) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

RNAC:USA 1S7:Germany

Address

65 Grove Street, Watertown, MA, USA, 02472

Website

https://www.selectabio.com

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Cartesian Therapeutics (STU:1S70) Headlines

No Headlines